2A Pharma ApS: Financial statements 2021
CVR: 39391597
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
2A Pharma ApS (CVR 39391597) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,948,298 and a net result of DKK 271,693 compared with DKK 322,401 the year before. That is a decrease of 7.1% compared with the year before. Equity in the 2021 report amounted to DKK 938,470. The solvency ratio was 70.9%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,948,298
- Profit/Loss
- DKK 271,693
- Equity
- DKK 938,470
- Total Assets
- DKK 1,323,342
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 1.9 mio. | 272 t. | 938 t. | 2 |
| 2020 | - | 2.1 mio. | 322 t. | 667 t. | 3 |
| 2019 | - | 1.5 mio. | -81 t. | 344 t. | 1 |
| 2018 | - | 947 t. | -60 t. | 426 t. | 1 |
Official annual report
Find more companies like 2A Pharma ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
2A Pharma ApS has published its annual report for 2020. Gross profit came to DKK 2,096,492, and the net result was DKK 322,401.
About 2A Pharma ApS
2A Pharma ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Preben Bruun-Nyzell and Josephus Dirk Vestergaard Nieland. The company is owned by 2A Pharma AB. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 587,253 and a net result of DKK -712,675 compared with DKK 4,297 the year before. Equity in the 2025 report amounted to DKK 263,490.